Episode 126: AML Series, Pt 12 - Treatment of patients with relapsed/refractory disease
The Fellow on Call: The Heme/Onc Podcast
Advancements in AML Treatment Options
This chapter explores innovative treatment strategies for patients with relapsed or refractory acute myeloid leukemia (AML), focusing on combination therapies and specific targeted agents. Key studies and patient case analyses illustrate the impact of these therapies on response rates and survival outcomes, emphasizing the ongoing need for randomized trials to validate these findings.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
